Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

LEO 90100 in the Treatment of Psoriasis Vulgaris

NCT01536938 is registered in ClinicalTrials.gov with LEO Pharma as lead sponsor.

NCT NCT01536938
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01536938 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
LEO 90100 in the Treatment of Psoriasis Vulgaris
Lead sponsor
LEO Pharma
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2012
Completion date
November 30, 2012
Enrollment
303 (actual)
Sites
33

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis vulgaris